Prognostic impact of rapid reduction of involved free light chains in multiple myeloma patients under first-line treatment with Bendamustine, Prednisone, and Bortezomib (BPV)
暂无分享，去创建一个
M. Scholz | U. Platzbecker | S. Schwind | W. Pönisch | Georg-Nikolaus Franke | Y. Remane | D. Hammerschmidt | M. Schwarz | A. Schwarzer | M. Jentzsch | J. Grimm | Song-Yau Wang | T. Holzhey | Thomas Zehrfeld | F. Hoffmann | C. Becker | L. Braunert | T. Edelmann | Madlen Holzvogt | Bruno Holzvogt | M. Andrea | Uta Schönfelder-Fricke | Markus Bill | G. Franke | T. Zehrfeld | M. Holzvogt